We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T Turnover 8.35%
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
425
Increased
3,807
Reduced
3,215
Closed
303
Avg Time Held
7.3 years
Top 10 Avg Time Held
6.6 years
Top 20 Avg Time Held
5.7 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX icon
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KLIC icon
1351
Kulicke & Soffa
KLIC
$4.35B
$129M 0.01%
966,277
+15,793
+2% +$1.55M
2013 Q2
52 quarters
FUN icon
1352
Cedar Fair
FUN
$875M
$129M 0.01%
6,060,863
+136,436
+2% +$2.79M
2013 Q2
52 quarters
CYTK icon
1353
Cytokinetics
CYTK
$8.89B
$129M 0.01%
1,510,318
+5,243
+0.3% +$376K
2013 Q3
51 quarters
TXG icon
1354
10x Genomics
TXG
$9.43B
$129M 0.01%
3,351,911
+695,558
+26% +$18.2M
2019 Q3
27 quarters
SKM icon
1355
SK Telecom
SKM
$12.6B
$128M 0.01%
3,994,323
+944,949
+31% +$35M
2013 Q2
52 quarters
LNC icon
1356
Lincoln National
LNC
$7.66B
$128M 0.01%
3,632,194
-60,648
-2% -$2.18M
2013 Q2
52 quarters
ESLT icon
1357
Elbit Systems
ESLT
$34.8B
$128M 0.01%
169,101
+4,875
+3% +$4.05M
2013 Q2
52 quarters
WTS icon
1358
Watts Water Technologies
WTS
$11.9B
$128M 0.01%
327,665
+129,141
+65% +$40.3M
2013 Q2
52 quarters
OSK icon
1359
Oshkosh
OSK
$7.95B
$128M 0.01%
835,651
-33,002
-4% -$4.65M
2013 Q2
52 quarters
ORI icon
1360
Old Republic International
ORI
$9.34B
$128M 0.01%
3,133,860
+44,826
+1% +$1.78M
2013 Q2
52 quarters
TAL icon
1361
TAL Education Group
TAL
$6.96B
$128M 0.01%
13,396,879
+451,328
+3% +$4.74M
2013 Q2
52 quarters
SLQD icon
1362
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
$128M 0.01%
2,544,555
+167,293
+7% +$8.43M
2014 Q1
49 quarters
UUUU icon
1363
Energy Fuels
UUUU
$2.27B
$128M 0.01%
8,830,755
+2,559,086
+41% +$47M
2017 Q1
37 quarters
AVUS icon
1364
Avantis US Equity ETF
AVUS
$14.7B
$128M 0.01%
999,429
+26,031
+3% +$3.21M
2020 Q4
22 quarters
IYJ icon
1365
iShares US Industrials ETF
IYJ
$2.02B
$128M 0.01%
767,063
-13,225
-2% -$2.08M
2013 Q2
52 quarters
MXL icon
1366
MaxLinear
MXL
$7.09B
$128M 0.01%
998,223
+120,153
+14% +$8.5M
2013 Q3
51 quarters
SPXC icon
1367
SPX Corp
SPXC
$8.39B
$128M 0.01%
520,845
+60,092
+13% +$13.1M
2013 Q2
52 quarters
PRIM icon
1368
Primoris Services
PRIM
$3.97B
$127M 0.01%
1,284,470
+728,723
+131% +$95.8M
2013 Q2
52 quarters
GLTR icon
1369
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.51B
$127M 0.01%
701,720
+36,570
+5% +$7.73M
2013 Q2
52 quarters
AXGN icon
1370
Axogen
AXGN
$2.09B
$127M 0.01%
2,747,924
-375,058
-12% -$15.1M
2013 Q4
50 quarters
XPEV icon
1371
XPeng
XPEV
$9.23B
$127M 0.01%
9,586,523
+4,137,650
+76% +$65.6M
2020 Q3
23 quarters
GVA icon
1372
Granite Construction
GVA
$4.83B
$126M 0.01%
799,000
-51,159
-6% -$6.95M
2013 Q2
52 quarters
OWL icon
1373
Blue Owl Capital
OWL
$6.13B
$126M 0.01%
14,434,733
+1,207,148
+9% +$11.5M
2020 Q4
22 quarters
BBIO icon
1374
BridgeBio Pharma
BBIO
$13.1B
$126M 0.01%
1,693,652
-183,707
-10% -$12.9M
2019 Q2
28 quarters
IHI icon
1375
iShares US Medical Devices ETF
IHI
$3.75B
$126M 0.01%
2,549,908
-678,388
-21% -$34.4M
2013 Q2
52 quarters

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.